Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Fukang Pharmaceutical Biotechnology is a Chinese life sciences company based in Changchun, Jilin Province, specializing in the research and development of biotechnological products and pharmaceutical intermediates. Established in 2017, the company focuses on the production of health supplements, medical devices, and functional food products. It operates within the regional biotechnology cluster of Northeast China, leveraging local resources for pharmaceutical manufacturing and R&D. The company's activities encompass the value chain from initial research to the commercial distribution of health-related products. Its business scope also includes the development of biochemical reagents and the provision of technical services within the pharmaceutical sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 吉林福康医药生物科技.